相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective
Christopher Ross et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2016)
Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria
Martin Inzinger et al.
ACTA DERMATO-VENEREOLOGICA (2016)
Gender differences in quality of care experiences during hospital stay: A contribution to patient-centered healthcare for both men and women
T. A. M. Teunissen et al.
PATIENT EDUCATION AND COUNSELING (2016)
Long-Term Efficacy, Safety and Drug Survival of Ustekinumab in a Spanish Cohort of Patients with Moderate to Severe Plaque Psoriasis
Lluis Puig et al.
DERMATOLOGY (2015)
Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients
Florenzo Lannone et al.
JOINT BONE SPINE (2015)
Efficacy and Safety of Systemic Long-Term Treatments for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis
Alexander Nast et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
Richard B. Warren et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
R. Gniadecki et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Predictors of adalimumab drug survival in psoriasis differ by reason for discontinuation: long-term results from the Bio-CAPTURE registry
J. M. P. A. van den Reek et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Diet and physical exercise in psoriasis: a randomized controlled trial
L. Naldi et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Comparing treatment goals for psoriasis with treatment decisions in daily practice: results from a prospective cohort of patients with psoriasis treated with biologics: BioCAPTURE
J. Zweegers et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network
J. M. P. A. van den Reek et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: a single-centre database analysis
S. P. Menting et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Determinants of drug survival for etanercept in a long-term daily practice cohort of patients with psoriasis
J. M. P. A. van den Reek et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Treatment Adherence to Different Etanercept Regimens, Continuous vs. Intermittent, in Patients Affected by Plaque-Type Psoriasis
Maria Esposito et al.
DRUG DEVELOPMENT RESEARCH (2014)
The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial
Nawaf Al-Mutairi et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Long-term study of infliximab for psoriasis in daily practice: drug survival depends on combined treatment, obesity and infusion reactions
J. Spertino et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry
J. M. Carrascosa et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Efficacy and drug survival of anti-tumour necrosis factor-alpha therapies in patients with non-radiographic axial spondyloarthritis: an observational cohort study from Southern Sweden
A. Gulfe et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2014)
Biomarkers in psoriasis and psoriatic arthritis
Federica Villanova et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Survival rate of antitumour necrosis factor- treatments for psoriasis in routine dermatological practice: a multicentre observational study
M. Esposito et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Adalimumab for the treatment of psoriasis in real life: a retrospective cohort of 119 patients at a single Spanish centre
A. Lopez-Ferrer et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Drug survival rates in patients with psoriasis after treatment with biologics
Yoshinori Umezawa et al.
JOURNAL OF DERMATOLOGY (2013)
Risk of Serious Adverse Events Associated With Biologic and Nonbiologic Psoriasis Systemic Therapy
Gregorio Carretero
ARCHIVES OF DERMATOLOGY (2012)
Drug survival rates of biologic treatments in patients with psoriasis vulgaris
A. M. G. Brunasso et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis
Vito Di Lernia et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2012)
Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
R. Gniadecki et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Responses to ustekinumab in the anti-TNF agent-naive vs. anti-TNF agent-exposed patients with psoriasis vulgaris
A. Clemmensen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
European S3-Guidelines on the systemic treatment of psoriasis vulgaris
D. Pathirana et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes
Emma C. Davies et al.
PLOS ONE (2009)
Impact of Body Mass Index and Obesity on Clinical Response to Systemic Treatment for Psoriasis
Luigi Naldi et al.
DERMATOLOGY (2008)
分享论文
